Digital Goa, Oct 6 – Goa FDA has issued a public alert and stop-use notice regarding Coldrif Syrup (Batch No. SR-13) manufactured by M/s Sresan Pharmaceutical, following reports of child deaths in Madhya Pradesh linked to toxic adulteration. According to the FDA, the Madhya Pradesh Food and Drugs Administration found that the syrup, containing Paracetamol, Phenylephrine Hydrochloride, and Chlorpheniramine Maleate, was allegedly adulterated with Diethylene Glycol (DEG) — a toxic substance — at 46.28% concentration. All chemists, druggists, pharmacies, and distributors in Goa have been directed to immediately stop the sale and distribution of the said batch and report any stock to the Directorate without delay. The public has also been urged to stop using Coldrif Syrup, Batch No. SR-13 (Mfg. May 2025, Exp. April 2027) and report possession of the product to the Directorate at off-dfda.gou@nic.in.
